This symposium, sponsored by Endoceutics, took place during the 2015 ESG congress in Prague. It focused on the role and importance of DHEA in female sexual organ dysfunction during menopause, especially in vulvovaginal atrophy and dyspareunia. DHEA is a precursor of androgens and estrogens that occurs at the highest levels at the age of thirty and then decreases on average by 60 percent at menopause. DHEA substitution and routes of administration were the subject of the reports and the discussions that follow.
This symposium, sponsored by Endoceutics, took place during the 2015 ESG congress in Prague. It focused on the role and importance of DHEA in female sexual organ dysfunction during menopause, especially in vulvovaginal atrophy and dyspareunia. DHEA is a precursor of androgens and estrogens that occurs at the highest levels at the age of thirty and then decreases on average by 60 percent at menopause. DHEA substitution and routes of administration were the subject of the reports and the discussions that follow.
full talks
DHEA and local sex steroid formation
Questions & Answers
The clinical pictures of vulvovaginal atrophy
Questions & Answers
Efficacy of intravaginal prasterone on the VVA signs and syntoms
Final discussion
interviste
DHEA efficacy in the treatment of VVA and dyspareunia
Vulvovaginal postmenopausal disfunctions
The role of androgens in the vulvovaginal disfunctions
Prasterone (DHEA): meccanismi d'azione e proprietà terapeutiche
Prasterone (DHEA): action mechanisms and therapeutic properties
